Subscribe To
Will caterpillar (cat) beat estimates again in its next earnings report?
Caterpillar (CAT) has an impressive earnings surprise history and currently possesses the right combina...
October 3, 2023, 1:32 pm
The hunt for potential 10x returns: will caterpillar stock continue to climb?
I examine whether Caterpillar has the potential to appreciate ten times over with its current valuation...
October 3, 2023, 1:09 pm
Here is what to know beyond why caterpillar inc. (cat) is a trending stock
Caterpillar (CAT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is w...
October 3, 2023, 10:31 am
Caterpillar: digging deep into value
Caterpillar demonstrates stellar financial performance in the current uncertain environment. The compan...
October 3, 2023, 1:51 am
Why shares of structure therapeutics are up monday
Analysts upgraded their price targets for Structure Therapeutics. The company's obesity therapy can be taken as a once-daily ...
October 2, 2023, 3:48 pm
Caterpillar: making itself indispensable to its customers
Caterpillar is making itself indispensable to its customers in the mining industry by providing complet...
October 2, 2023, 2:15 pm
Tex vs. cat: which stock should value investors buy now?
Investors interested in stocks from the Manufacturing - Construction and Mining sector have probably already heard of Terex (TEX) and Cater...
October 2, 2023, 12:46 pm
Cad, rupee under pressure as oil price surge spills into oct-dec quarter
The increase in international crude oil prices has spilled over into the October – December quarter, ...
October 2, 2023, 8:14 am
11%-yielding horizon technology: a smart monthly payer to buy
Horizon Technology Finance is a high-dividend monthly payer that has given shareholders strong total returns. It focuses on growth sectors and generat...
October 2, 2023, 8:10 am
United utilities pledges £13.7 billion investment to cut spills
United Utilities PLC unveiled plans for £13.7 billion of investment as it pledged the UK's biggest spill...
October 2, 2023, 2:47 am
Kalvista's sebetralstat: a pill worth swallowing in hae
KalVista Pharmaceuticals is positioned to disrupt the HAE treatment landscape with its oral therapy, sebetralstat, offering rapid symptom relief and i...
October 1, 2023, 12:05 am
An ‘iceberg' awaits with only 10% of the junk-bond market feeling the pinch of higher rates, says bofa global
U.S. companies binged on debt when rates were super low, so they wouldn't have to swallow the bitter pill...
September 29, 2023, 3:38 pm
Shares of biotech startup structure therapeutics surge more than 30% on promising obesity pill data
Structure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic...
September 29, 2023, 12:02 pm
Ticking time bombs: 3 manufacturing stocks to dump before the damage is done
The manufacturing sector is one of the pillars of the global economy, producing goods and services that...
September 29, 2023, 8:23 am
4 must-buy stocks for stellar earnings growth
Invest in stocks such as Eaton (ETN), Caterpillar (CAT), ITT and Kinsale Capital (KNSL) at the moment f...
September 29, 2023, 8:16 am
3m: a 7%-yielding, 30% undervalued dumpster fire
3M Company's stock is trading significantly below its all-time high, down 22% year-to-date. The company recently settled a historic $6 billion lawsuit...
September 29, 2023, 7:54 am
Severn trent to raise £1 billion as pledges to tackle leaks and spills
Severn Trent PLC (LSE:SVT) moved to bolster its finances unveiling a £1 billion fund raise including a £500 investment from Qatar Investment Authori...
September 29, 2023, 2:52 am
Improving sentiment should propel this uranium mining etf
More capital investment in uranium projects is expected to rise as sentiment improves globally. As a byproduct of increased demand for uranium, this s...
September 28, 2023, 12:26 pm
Albemarle (alb)-caterpillar join forces for sustainable mining
Albemarle (ALB) and Caterpillar team up to develop a more sustainable battery supply chain, including z...
September 28, 2023, 11:17 am
Gsk lifts growth ambitions for hiv business on long-acting drug
GSK on Thursday lifted its medium-term growth forecast for its HIV drugs business ViiV, encouraged by strong sales of long-acting injections that aim ...
September 28, 2023, 9:05 am